ID   AMC-HN-3
AC   CVCL_5961
SY   Amc-HN-3; AMC-HN3; Asian Medical Center-Head and Neck cancer-3
DR   cancercelllines; CVCL_5961
DR   Wikidata; Q54749709
RX   PubMed=9349880;
RX   PubMed=24336076;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Heterozygous (PubMed=24336076).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
RX   PubMed=9349880; DOI=10.3109/00016489709113477;
RA   Kim S.Y., Chu K.-C., Lee H.R., Lee K.-S., Carey T.E.;
RT   "Establishment and characterization of nine new head and neck cancer
RT   cell lines.";
RL   Acta Oto-Laryngol. 117:775-784(1997).
//
RX   PubMed=24336076; DOI=10.1038/cddis.2013.488; PMCID=PMC3877559;
RA   Roh J.-L., Kim E.H., Park H.B., Park J.Y.;
RT   "The Hsp90 inhibitor 17-(allylamino)-17-demethoxygeldanamycin
RT   increases cisplatin antitumor activity by inducing p53-mediated
RT   apoptosis in head and neck cancer.";
RL   Cell Death Dis. 4:e956.1-e956.8(2013).
//